内微生物与瘤免疫之间的交叉语音:对瘤治疗的影响
Fengxue Li1, Lili Qiao2, Xinquan Liang3
1Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
Cancer medicine
|January 27, 2026
概括
瘤免疫微环境 (TIME) 中的瘤内微生物群 (ITM) 影响癌症的进展和治疗反应. 了解ITM 的理解
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 新出现的证据揭示了瘤和免疫细胞内的微生物,这些微生物被称为瘤内微生物群 (ITM).
- ITM显著影响瘤免疫微环境 (TIME),影响瘤进展和治疗结果.
研究的目的:
- 审查内细菌和真菌的分布和功能.
- 探索ITM和时间之间的相关性.
- 为癌症治疗提供基于ITM的治疗策略的见解.
主要方法:
- 在PubMed.com上进行了全面的文献搜索.
- 搜索术语涵盖了ITM,癌症,时间和治疗应用的各个方面.
- 选了关于ITM分布,机制和治疗潜力的文学研究.
主要成果:
- 细菌和真菌在瘤中表现出多样化的分布,通过免疫应答调节和信号通路参与等机制产生支持或反瘤效应.
- ITM影响化疗,放射治疗和免疫治疗的疗效.
- 虽然一些基于微生物的疗法正在临床使用,但需要进一步的研究来确定因果关系并实现精确的调制.
结论:
- 内微生物群是增强癌症免疫疗法的有希望的目标.
- 未来的研究应该优先确定因果关系和ITM的精确调制,以便在瘤学中进行翻译应用.
相关概念视频
Tumor Immunotherapy
1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
The Tumor Microenvironment
7.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Loss of Tumor Suppressor Gene Functions
6.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.0K
Cancer Stem Cells and Tumor Maintenance
6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
What is the Immune System?
127.5K
Overview
127.5K


